mitomycin has been researched along with manganese in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arakawa, Y; Kawakami, H; Nagaoka, S; Nakamura, K; Ohse, T | 1 |
| Anderson, T; Hester, K; Kirrane, E; Kulikowski, N; Lehmann, DM; Simmons, JE | 1 |
2 other study(ies) available for mitomycin and manganese
| Article | Year |
|---|---|
Cell death by reactive oxygen species generated from water-soluble cationic metalloporphyrins as superoxide dismutase mimics.
Topics: Animals; Antineoplastic Agents; Antioxidants; Cell Death; Cisplatin; Copper; DNA Damage; Iron; Manganese; Metalloporphyrins; Mitomycin; Molecular Mimicry; Rats; Reactive Oxygen Species; Solubility; Superoxide Dismutase; Tumor Cells, Cultured; Water | 2001 |
Environmental exposure to metals and the development of tauopathies, synucleinopathies, and TDP-43 proteinopathies: A systematic evidence map protocol.
Topics: Aluminum; Antimony; Antineoplastic Combined Chemotherapy Protocols; Arsenic; Barium; Beryllium; Cadmium; Chromium; Cisplatin; Classification; Cobalt; Copper; Doxorubicin; Environmental Exposure; Humans; Manganese; Mercury; Mitomycin; Neurodegenerative Diseases; Nickel; Palladium; Radium; Review Literature as Topic; Silver; Synucleinopathies; Tauopathies; TDP-43 Proteinopathies; Vanadium; Zinc | 2022 |